Wedge Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.58M | Sell |
|
|||||
|
2025
Q2 | $1.58M | Sell |
|
|||||
|
2025
Q1 | $1.62M | Sell |
|
|||||
|
2024
Q4 | $1.78M | Sell |
|
|||||
|
2024
Q3 | $3.5M | Sell |
|
|||||
|
2024
Q2 | $3.95M | Sell |
|
|||||
|
2024
Q1 | $5.59M | Buy |
|
|||||
|
2023
Q4 | $3.61M | Buy |
|
|||||
|
2023
Q3 | $3.69M | Sell |
|
|||||
|
2023
Q2 | $5.79M | Sell |
|
|||||
|
2023
Q1 | $4.72M | Sell |
|
|||||
|
2022
Q4 | $5M | Sell |
|
|||||
|
2022
Q3 | $4.17M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $233K | Buy |
|
|||||
|
2019
Q4 | $331K | Buy |
|
|||||
|
2019
Q3 | $318K | Sell |
|
|||||
|
2019
Q2 | $607K | Buy |
|
|||||
|
2019
Q1 | $480K | Buy |
|